Risultati della ricerca - Darren R. Feldman
- Mostra 1 - 20 risultati su 64
- Vai alla pagina seguente
-
1
-
2
-
3
Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors di Darren R. Feldman, Wendy Schaffer, Richard M. Steingart
Pubblicazione 2012Revisão -
4
Testicular cancer in 2023: Current status and recent progress di Deaglan Joseph McHugh, Jack P. Gleeson, Darren R. Feldman
Pubblicazione 2023Revisão -
5
-
6
-
7
-
8
-
9
High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis di Russell Moore, Nelly G. Adel, Elyn Riedel, Manisha Bhutani, Darren R. Feldman, Nour Elise Tabbara, Gerald A. Soff, Rekha Parameswaran, Hani Hassoun
Pubblicazione 2011Artigo -
10
Progression‐free and overall survival in patients with relapsed/refractory germ cell tumors treated with single‐agent chemotherapy: Endpoints for clinical trial design di Darren R. Feldman, Sujata Patil, M. J. Trinos, Maryann Carousso, Michelle S. Ginsberg, Joel Sheinfeld, Dean F. Bajorin, George J. Bosl, Robert J. Motzer
Pubblicazione 2011Artigo -
11
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma di Michael S. Hofman, Ben Tran, Darren R. Feldman, Anna Pokorska-Bocci, Solen Pichereau, Jonathan Wessen, Mohammad B. Haskali, Richard Sparks, Olena Vlasyuk, Ivana Galetić
Pubblicazione 2024Artigo -
12
Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhi... di Francesca Cavallo, Grazia Graziani, Cristina Antinozzi, Darren R. Feldman, Jane Houldsworth, George J. Bosl, R. S. K. Chaganti, Mary Ellen Moynahan, Maria Jasin, Marco Barchi
Pubblicazione 2012Artigo -
13
Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors di James E. Korkola, Jane Houldsworth, Darren R. Feldman, Adam B. Olshen, Li-Xuan Qin, Sujata Patil, Victor E. Reuter, George J. Bosl, R. S. K. Chaganti
Pubblicazione 2009Artigo -
14
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors di Samuel A. Funt, Sujata Patil, Darren R. Feldman, Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Satish K. Tickoo, Victor E. Reuter, George J. Bosl
Pubblicazione 2019Artigo -
15
-
16
Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma di Darren R. Feldman, Michael Baum, Michelle S. Ginsberg, Hani Hassoun, Carlos D. Flombaum, Susanne Velasco, Patricia Fischer, Ellen A. Ronnen, Nicole Ishill, Sujata Patil, Robert J. Motzer
Pubblicazione 2009Artigo -
17
TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis di Darren R. Feldman, Joel Sheinfeld, Dean F. Bajorin, Patricia Fischer, Stefan Turkula, Nicole Ishill, Sujata Patil, Manjit S. Bains, Lilian Reich, George J. Bosl, Robert J. Motzer
Pubblicazione 2010Artigo -
18
-
19
Sarcomatoid-variant Renal Cell Carcinoma di Ana M. Molina, Satish K. Tickoo, Nicole Ishill, M. J. Trinos, Lawrence H. Schwartz, Sujata Patil, Darren R. Feldman, Victor E. Reuter, Paul Russo, Robert J. Motzer
Pubblicazione 2010Artigo -
20
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma di Ana M. Molina, Darren R. Feldman, Michelle S. Ginsberg, Glenn S. Kroog, Satish K. Tickoo, Xiaoyu Jia, Murielle Georges, Sujata Patil, Michael Baum, Victor E. Reuter, Robert J. Motzer
Pubblicazione 2010Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Oncology
Cancer
Chemotherapy
Biology
Renal cell carcinoma
Germ cell tumors
Genetics
Gene
Surgery
Cisplatin
Cancer research
Gastroenterology
Pathology
Testicular cancer
Urology
Adverse effect
Confidence interval
Sunitinib
Clear cell renal cell carcinoma
Clinical endpoint
Clinical trial
Disease
Progression-free survival
Biochemistry
Environmental health
Etoposide
Hazard ratio
Kidney cancer